Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Preclinical Development and Validation of a Hematopoietic Stem Cell-Based Lentivector Treatment for Hemophilia a

Christopher B Doering, PhD, Gabriela Denning, PhD, Jordan E Shields, MS, William Swaney, Lilith Reeves, Punam Malik, MD, H. Trent Spencer, PhD

Blood (2015) 126 (23): 4421.

https://doi.org/10.1182/blood.V126.23.4421.4421

Published: 2015

Journal Articles

The Human Kell Blood Group Binds the Erythroid 4.1R Protein: New Insights into the 4.1R-Dependent Red Cell Membrane Complex

Slim Azouzi, Emmanuel Collec, Narla Mohandas, DSc, Xiuli An, MD PhD, Yves Colin Aronovicz, Caroline Le Van Kim

Blood (2015) 126 (23): 3334.

https://doi.org/10.1182/blood.V126.23.3334.3334

Published: 2015

Journal Articles

Bioengineered Coagulation Factor VIII Enables Long-Term Correction Of Murine Hemophilia A Following Liver-Directed Adeno-Associated Viral Vector Delivery

Harrison C. Brown, BBA, Jordan E Shields, Shangzhen Zhou, MD, J. Fraser Wright, PhD, H. Trent Spencer, PhD, Christopher B Doering, PhD

Blood (2013) 122 (21): 4210.

https://doi.org/10.1182/blood.V122.21.4210.4210

Published: 2013

Journal Articles

Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11

Soohee Lee, Asim K. Debnath, Colvin M. Redman

Blood (2003) 102 (8): 3028–3034.

https://doi.org/10.1182/blood-2003-05-1564

Published: 2003

Journal Articles

Expression of Kell blood group protein in nonerythroid tissues

David Russo, Xu Wu, Colvin M. Redman, Soohee Lee

Blood (2000) 96 (1): 340–346.

https://doi.org/10.1182/blood.V96.1.340

Published: 2000

Journal Articles

Proteolytic Processing of Big Endothelin-3 by the Kell Blood Group Protein: Presented in part in abstract form at the 40 th annual meeting of the American Society of Hematology, December, 1998.

Soohee Lee, Melissa Lin, Aldo Mele, Ying Cao, James Farmar, David Russo, Colvin Redman

Blood (1999) 94 (4): 1440–1450.

https://doi.org/10.1182/blood.V94.4.1440

Published: 1999

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Preclinical Development and Validation of a Hematopoietic Stem Cell-Based Lentivector Treatment for Hemophilia a

The Human Kell Blood Group Binds the Erythroid 4.1R Protein: New Insights into the 4.1R-Dependent Red Cell Membrane Complex

Bioengineered Coagulation Factor VIII Enables Long-Term Correction Of Murine Hemophilia A Following Liver-Directed Adeno-Associated Viral Vector Delivery

Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11

Expression of Kell blood group protein in nonerythroid tissues

Proteolytic Processing of Big Endothelin-3 by the Kell Blood Group Protein: Presented in part in abstract form at the 40 th annual meeting of the American Society of Hematology, December, 1998.

Email alerts

ASH Publications

American Society of Hematology

Update search

Preclinical Development and Validation of a Hematopoietic Stem Cell-Based Lentivector Treatment for Hemophilia a

The Human Kell Blood Group Binds the Erythroid 4.1R Protein: New Insights into the 4.1R-Dependent Red Cell Membrane Complex

Bioengineered Coagulation Factor VIII Enables Long-Term Correction Of Murine Hemophilia A Following Liver-Directed Adeno-Associated Viral Vector Delivery

Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11

Expression of Kell blood group protein in nonerythroid tissues

Proteolytic Processing of Big Endothelin-3 by the Kell Blood Group Protein: Presented in part in abstract form at the 40 th annual meeting of the American Society of Hematology, December, 1998.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only